🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The reason for this study is to see if lasmiditan is safe and effective in ...
Status
Terminated
Location
Central Research Associates
Start Date
2020-06-15
Trial ID
NCT04396236
Treatments Being Tested
The reason for this study is to see how effective and safe the study drug k...
Status
Completed
Location
Rehabilitation & Neurological Services LLC
Start Date
2019-06-24
Trial ID
NCT03670810
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of a range...
Status
Completed
Location
Multiple Locations
Start Date
2009-07
Trial ID
NCT00883051
Treatments Being Tested
The purpose of this study is to assess whether taking lasmiditan and sumatr...
Status
Completed
Location
Covance Daytona Beach
Start Date
2017-10-17
Trial ID
NCT03310411
Treatments Being Tested
This is a prospective randomized, double-blind, placebo-controlled study in...
Status
Completed
Location
Southview Medical Group, P.C.
Start Date
2015-04
Trial ID
NCT02439320
Treatments Being Tested
The purpose of this study is to look at how much lasmiditan, study drug, ge...
Status
Completed
Location
Covance Daytona Beach
Start Date
2017-08-15
Trial ID
NCT03252015
Treatments Being Tested
This is a prospective randomized, double-blind, placebo-controlled study in...
Status
Completed
Location
Alabama Clinical Therapeutics, LLC
Start Date
2016-05
Trial ID
NCT02605174
Treatments Being Tested
The purpose of this study was to determine how two doses of lasmiditan affe...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician.
Start Date
2011-09-16
Trial ID
NCT03465436
Treatments Being Tested